Journal of Controlled Release : Official Journal of the Controlled Release Society 1998: Vol 53 Index

7 Pages·1998·1.2 MB·English

journal of
controlled
release
Journal of Controlled Release 53 (1998) 311-313
Author Index Volume 53 (1998)
Ahn, B.-Y., see Cho, N.-H. (53) 215 Dankert, J., see Kuijpers, A.J. (53) 235
Akaike, T., see Kim, J.-S. (53) 175 Dedrick, R.L., see Flessner, M.F. (53) 69
Andersen, C., see Br@ndsted, H. (53) 7 DeSilva, B.S., see Topp, E.M. (53) 15
Aoyagi, T., see Chung, J.E. (53) 119 Dumoulin, Y., see Lenaerts, V. (53) 225
August, J.T., see Leong, K.W. (53) 183
Aukerman, L., see Cappello, J. (53) 105 Engbers, G.H.M., see Kuijpers, A.J. (53) 235
Aynie, I., see Fattal, E. (53) 137 Engel, R., see Vert, M. (53) 85
Bae, Y.H., Vernon, B., Han, C.K. and Kim, S.W., Extracellular Farr, S.J., see Gonda, I. (53) 269
matrix for a rechargeable cell delivery system (53) 249 Fattal, E., Vauthier, C., Aynie, I., Nakada, Y., Lambert, G., Malvy,
Barenholz, Y., see Gabizon, A. (53) 275 C. and Couvreur, P., Biodegradable polyalkylcyanoacrylate
Brgndsted, H., Andersen, C. and Hovgaard, L., Crosslinked nanoparticles for the delivery of oligonucleotides (53) 137
dextran — a new capsule material for colon targeting of drugs Feijen, J., see Kuijpers, A.J. (53) 235
(53) 7 Ferrari, F.A., see Cappello, J. (53) 105
Brown, J.E., see Markou, C.P. (53) 281 Flessner, M.F. and Dedrick, R.L., Tissue-level transport mecha-
Burman, D., see Cappello, J. (53) 105 nisms of intraperitoneally-administered monoclonal antibodies
(53) 69
Cappello, J., Crissman, J.W., Crissman, M., Ferrari, F.A., Textor, Freire, E., see Milstein, S.J. (53) 259
G., Wallis, O., Whitledge, J.R., Zhou, X., Burman, D., Au-
kerman, L. and Stedronsky, E.R., In-situ self-assembling Gabizon, A., Goren, D., Cohen, R. and Barenholz, Y., Develop-
protein polymer gel systems for administration, delivery, and ment of liposomal anthracyclines: from basics to clinical
release of drugs (53) 105 applications (53) 275
Cartilier, L., see Lenaerts,V . (53) 225 Gentry, C., see Omelyanenko, V. (53) 25
Chan Kwon, I., see Cho, N.-H. (53) 215 Gonda, I., Schuster, J.A., Rubsamen, R.M., Lloyd, P., Cipolla, D.
Cherng, J.-Y., see van de Wetering, P. (53) 145 and Farr, S.J., Inhalation delivery systems with compliance
Cho, B.K., see Kranz, D.M. (53) 77 and disease management capabilities (53) 269
Cho, N.-H., Seong, S.-Y., Chun, K.-H., Kim, Y.-H., Chan Kwon, Goren, D., see Gabizon, A. (53) 275
I., Ahn, B.-Y. and Jeong, S.Y., Novel mucosal immunization Gruber, M.M., see Kranz, D.M. (53) 77
with polysaccharide—protein conjugates entrapped in alginate
microspheres (53) 215 Haller, M.F. and Saltzman, W.M., Nerve growth factor delivery
Chouinard, F., see Lenaerts, V. (53) 225 systems (53) 1
Chun, K.-H., see Cho, N.-H. (53) 215 Han, C.K., see Bae, Y.H. (53) 249
Chung, J.E., Yokoyama, M., Aoyagi, T., Sakurai, Y. and Okano, Hanson, S.R., see Markou, C.P. (53) 281
T., Effect of molecular architecture of hydrophobically modi- Hashida, M., Takemura, S., Nishikawa, M. and Takakura, Y.,
fied poly(N-isopropylacrylamide) on the formation of ther- Targeted delivery of plasmid DNA complexed with galac-
moresponsive core-shell micellar drug carriers (53) 119 tosylated poly(L-lysine) (53) 301
Cipolla, D., see Gonda, I. (53) 269 Hendrickson, T.L., see Topp, E.M. (53) 15
Cohen, R., see Gabizon, A. (53) 275 Hennink, W.E., see van de Wetering, P. (53) 145
Coudane, J., see Vert, M. (53) 85 Hovgaard, L., see Brgndsted, H. (53) 7
Couvreur, P., see Fattal, E. (53) 137
Crissman, J.W., see Cappello, J. (53) 105 Jain, R.K., Delivery of molecular and cellular medicine to solid
Crissman, M., see Cappello, J. (53) 105 tumors (53) 49
Crommelin, D.J.A., see van de Wetering, P. (53) 145 Jeong, S.Y., see Cho, N.-H. (53) 215
PIT §0168-3659(98)00048-0
312 Author Index Volume 53 (1998)
Kasimova, M., see Milstein, S.J. (53) 259 unfolded proteins efficiently penetrate cell membranes —
Kataoka, K., see Yu, B.G. (53) 131 implications for oral drug delivery (53) 259
Kim, B.-I., see Kim, J.-S. (53) 175 Mlynek, G.M., see Milstein, S.J. (53) 259
Kim, J.-S., Kim, B.-I., Maruyama, A., Akaike, T. and Kim, S.W., Moss, S.H., see Pouton, C.W. (53) 289
A new non-viral DNA delivery vector: the terplex system (53)
Moussa, I., see Lenaerts, V. (53) 225
175
Kim, S.W., see Kim, J.-S. (53) 175 Nakada, Y., see Fattal, E. (53) 137
Kim, S.W., see Bae, Y.H. (53) 249 Nishikawa, M., see Hashida, M. (53) 301
Kim, Y.-H., see Cho, N.-H. (53) 215
Nugent, M.A., see Trinkaus-Randall, V. (53) 205
Kissel, T. and Werner, U., Nasal delivery of peptides: an in vitro
cell culture model for the investigation of transport and
Ohkawa, J., see Koseki, S. (53) 159
metabolism in human nasal epithelium (53) 195
Okano, T., see Chung, J.E. (53) 119
Kitos, P.A., see Topp, E.M. (53) 15
Okano, T., see Yu, B.G. (53) 131
Kopeéek, J., see Omelyanenko, V. (53) 25
Omelyanenko, V., Kopeckova, P., Gentry, C. and Kopecek, J.,
Kopeckova, P., see Omelyanenko, V. (53) 25
Targetable HPMA copolymer-adriamycin conjugates. Recog-
Koseki, S., Ohkawa, J., Yamamoto, R., Takebe, Y. and Taira, K.,
A simple assay system for examination of the inhibitory nition, internalization, and subcellular fate (53) 25
potential in vivo of decoy RNAs, ribozymes and other drugs
Pouton, C.W., Lucas, P., Thomas, B.J., Uduehi, A.N., Milroy, D.A.
by measuring the Tat-mediated transcription of a fusion gene
composed of the long terminal repeat of HIV-1 and a gene for and Moss, S.H., Polycation-DNA complexes for gene delivery:
a comparison of the biopharmaceutical properties of cationic
luciferase (53) 159
Kranz, D.M., Manning, T.C., Rund, L.A., Cho, B.K., Gruber, polypeptides and cationic lipids (53) 289
M.M. and Roy, E.J., Targeting tumor cells with bispecific Prestwich, G.D., Marecak, D.M., Marecek, J.F., Vercruysse, K.P.
antibodies and T cells (53) 77 and Ziebell, M.R., Controlled chemical modification of hy-
Krijgsveld, J., see Kuijpers, A.J. (53) 235 aluronic acid: synthesis, applications, and biodegradation of
Kuijpers, A.J., Engbers, G.H.M., van Wachem, P.B., Krijgsveld, J., hydrazide derivatives (53) 93
Zaat, S.A.J., Dankert, J. and Feijen, J., Controlled delivery of Pursley, M.D., see Markou, C.P. (53) 281
antibacterial proteins from biodegradable matrices (53) 235
Kwon, G., see Yu, B.G. (53) 131 Robinson, J.R., see Milstein, S.J. (53) 259
Roy, E.J., see Kranz, D.M. (53) 77
Lambert, G., see Fattal, E. (53) 137 Roy, K., see Leong, K.W. (53) 183
Leipold, H., see Milstein, S.J. (53) 259 Rubsamen, R.M., see Gonda, I. (53) 269
Lenaerts,V .,M oussa, I., Dumoulin, Y., Mebsout, F., Chouinard, F., Rund, L.A., see Kranz, D.M. (53) 77
Szabo, P., Mateescu, M.A., Cartilier, L. and Marchessault, R..,
Cross-linked high amylose starch for controlled release of Sakurai, Y., see Chung, J.E. (53) 119
drugs: recent advances (53) 225 Saltzman, W.M., see Haller, M.F. (53) 1
Leone-Bay, A., see Milstein, S.J. (53) 259 Sarubbi, D., see Milstein, S.J. (53) 259
Leong, K.W., Mao, H.-Q., Truong-Le, V.L., Roy, K., Walsh, S.M. Schuster, J.A., see Gonda, I. (53) 269
and August, J.T., DNA-polycation nanospheres as non-viral Schwach, G., see Vert, M. (53) 85
gene delivery vehicles (53) 183 Seong, S.-Y., see Cho, N.-H. (53) 215
Lloyd, P., see Gonda, I. (53) 269 Stedronsky, E.R., see Cappello, J. (53) 105
Low, P.S., see Wang, S. (53) 39 Szabo, P., see Lenaerts,V . (53) 225
Lucas, P., see Pouton, C.W. (53) 289
Taira, K., see Koseki, S. (53) 159
Malvy, C., see Fattal, E. (53) 137 Takakura, Y., see Hashida, M. (53) 301
Manning, T.C., see Kranz, D.M. (53) 77 Takebe, Y., see Koseki, S. (53) 159
Mao, H.-Q., see Leong, K.W. (53) 183 Takemura, S., see Hashida, M. (53) 301
Marchessault, R., see Lenaerts, V. (53) 225 Talsma, H., see van de Wetering, P. (53) 145
Marecak, D.M., see Prestwich, G.D. (53) 93 Textor, G., see Cappello, J. (53) 105
Marecek, J.F., see Prestwich, G.D. (53) 93 Thomas, B.J., see Pouton, C.W. (53) 289
Markou, C.P., Brown, J.E., Pursley, M.D. and Hanson, S.R., Topp, E.M., Kitos, P.A., Vijaykumar, V., DeSilva, B.S. and
Boundary layer drug delivery using a helical catheter (53) 281 Hendrickson, T.L., Antibody transport in cultured tumor cell
Maruyama, A., see Kim, J.-S. (53) 175 layers (53) 15
Mateescu, M.A., see Lenaerts, V. (53) 225 Trinkaus-Randall, V. and Nugent, M.A., Biological response to a
Mebsout, F., see Lenaerts, V. (53) 225 synthetic cornea (53) 205
Milroy, D.A., see Pouton, C.W. (53) 289 Truong-Le, V.L., see Leong, K.W. (53) 183
Milstein, S.J., Leipold, H., Sarubbi, D., Leone-Bay, A., Mlynek,
G.M., Robinson, J.R., Kasimova, M. and Freire, E., Partially Uduehi, A.N., see Pouton, C.W. (53) 289
Author Index Volume 53 (1998) 313
van de Wetering, P., Cherng, J.-Y., Talsma, H., Crommelin, D.J.A. tic drugs, imaging agents, and nucleic acids to cancer cells
and Hennink, W.E., 2-(dimethylamino)ethyl methacrylate (53) 39
based (co)polymers as gene transfer agents (53) 145 Werner, U., see Kissel, T. (53) 195
van Wachem, P.B., see Kuijpers, A.J. (53) 235 Whitledge, J.R., see Cappello, J. (53) 105
Vauthier, C., see Fattal, E. (53) 137
Vercruysse, K.P., see Prestwich, G.D. (53) 93 Yamamoto, R., see Koseki, S. (53) 159
Vernon, B., see Bae, Y.H. (53) 249 Yokoyama, M., see Chung, J.E. (53) 119
Vert, M., Schwach, G., Engel, R. and Coudane, J., Something new Yu, B.G., Okano, T., Kataoka, K. and Kwon, G., Polymeric
in the field of PLA/GA bioresorbable polymers? (53) 85 micelles for drug delivery: solubilization and haemolytic
Vijaykumar,V. , see Topp, E.M. (53) 15 activity of amphotericin B (53) 131
Wagner, E., Effects of membrane-active agents in gene delivery Zaat, S.A.J., see Kuijpers, A.J. (53) 235
(53) 155 Zhou, X., see Cappello, J. (53) 105
Wallis, O., see Cappello, J. (53) 105 Ziebell, M.R., see Prestwich, G.D. (53) 93
Walsh, S.M., see Leong, K.W. (53) 183
Wang, S. and Low, P.S., Folate-mediated targeting of antineoplas-

journal of
controlled
release
Journal of Controlled Release 53 (1998) 315-316
Subject Index Volume 53 (1998)
Adsorption, (53) 137 Dextran, (53) 7
Aerosols, (53) 269 Differentiated epithelia, (53) 289
Alginate, (53) 205 Diffusion and convection, (53) 49
Alginate microsphere, (53) 215 Diffusion, (53) 15, (53) 69
Alzheimer’s disease, (53) 1 Disease management, (53) 269
Amphipathic peptides, (53) 155 Drug release, (53) 7, (53) 25
Amphotericin B, (53) 131 Endocarditis, (53) 235
Angiogenesis, (53) 49 Endosome destabilization, (53) 155
Antibacterial proteins, (53) 235 Epidermal growth factor, (53) 1
Antibody binding, (53) 69 Folate receptor, (53) 77
Antisense oligonucleotide, (53) 175 Folate receptor-mediated endocytosis, (53) 39
Biocompatible hydrogel, (53) 93 AG (change in Gibbs free energy), (53) 259
Biodegradation, (53) 7 B-galactosidase, (53) 145
Biohybrid artificial pancreas, (53) 249 Galactosylated poly(1-lysine), (53) 301
Biomaterial, (53) 93 Gelatin, (53) 235
Bioresorbable polymers, (53) 85 Gene delivery, (53) 183, (53) 289
Bispecific antibodies, (53) 77 Gene therapy, (53) 289, (53) 301
Blood flow, (53) 49 Gene transfer, (53) 183
Cancer cell targeting, (53) 39 Growth factors, (53) 1, (53) 205
Cancer chemotherapy, (53) 39 HIV-1, (53) 159
Cancer detection and treatment, (53) 49 HPMA copolymer, (53) 25
Capsule, (53) 7 Haemolysis, (53) 131
Carbodiimide, (53) 235 Hepatic uptake, (53) 301
Cationic carriers, (53) 145 Human nasal epithelial cells, (53) 195
Cationic lipids, (53) 289 Hyaluronidase, (53) 93
Cell adhesion and deformation, (53) 49 Hydrocortisone, (53) 93
Cell culture model, (53) 195 Hydrolysis, (53) 85
Cell transplantation, (53) 1 Hydrophilic matrices, (53) 225
Colon-specific drug delivery, (53) 7 Hysteresis, (53) 249
Compliance, (53) 269 Immunoconjugates, (53) 15
Confocal microscopy, (53) 25 Immunoglobulin, (53) 69
Controlled release, (53) 1, (53) 205, (53) 225 Inhalation, (53) 269
Convection, (53) 15, (53) 69 Inhibition, (53) 159
Cross-linked starch, (53) 225 Initiator, (53) 85
Cross-linking, (53) 235 Intermediate conformation, (53) 259
Cytosolic delivery, (53) 155 Interstitial pressure, (53) 49
Cytotoxic T lymphocytes, (53) 77 Intracellular delivery, (53) 137
DNA condensation, (53) 289 Islets, (53) 249
DNA nanoparticles, (53) 183 Local drug delivery, (53) 281
DNA transfection, (53) 155 Luciferase, (53) 159
DNA, (53) 145 Lymphatics, (53) 49
Decoy, (53) 159 Microprocessors, (53) 269
Degradation mechanism, (53) 85 Model tumor, (53) 15
PIT $0168-3659(98)00049-2
316 Subject Index Volume 53 (1998)
Molten globule state, (53) 259 Protein polymer, (53) 105
Morphogen, (53) 1 Receptor—ligand binding, (53) 49 }
Mucosal immunization, (53) 215 Receptor-mediated gene delivery, (53) 155
N-Isopropylacrylamide copolymers, (53) 249 Ribozyme, (53) 159 F
Nanospheres, (53) 183 Sequential block copolymers, (53) 105 4
Nasal metabolism, (53) 195 Silk—elastinlike protein combinations, (53) 105 :
Nasal transport, (53) 195 Size distribution, (53) 131 i
Nerve growth factor, (53) 1 Subcellular trafficking, (53) 25 ;
Non-viral, (53) 183 Synthetic cornea, (53) 205
Oral vaccine, (53) 215 T,, (melting temperature), (53) 259
PEO-PBLA micelles, (53) 131 TEM, (53) 131
Passive diffusion, (53) 259 Targeted imaging agents, (53) 39
Peptides, (53) 195 Terminal modification, (53) 119
Pharmacokinetics, (53) 301 Terplex system, (53) 175
Phase transition, (53) 119 Thermoresponse, (53) 119 4
Plasmid DNA, (53) 301 Thermoreversible gelation, (53) 249 4
Pneumococcal pneumonia, (53) 215 Thrombosis, (53) 281
Poly(2-(dimethylamino)ethyl methacrylate), (53) 145 Tissue distribution, (53) 137
Poly(N-isopropylacrylamide), (53) 119 Transfection, (53) 145, (53) 175, (53) 289
Polyalkylcyanoacrylate nanoparticles, (53) 137 Transgenic mice, (53) 77
Polycations, (53) 289 Tumor microcirculation, (53) 49
Polyfunctional crosslinker, (53) 93 Tumor penetration, (53) 15
Polylactides, (53) 85 Vascular permeability, (53) 49
Polylysine, (53) 289 Wound repair, (53) 205
Polymeric micelle, (53) 119 Zero-order release, (53) 225
Polymer, (53) 1